<DOC>
	<DOC>NCT00327418</DOC>
	<brief_summary>A study to assess the efficacy of once daily atorvastatin 10 mg versus placebo on cardiovascular endpoints in patients with non-insulin-dependent diabetes mellitus (NIDDM) who have a history of either hypertension, retinopathy, microalbuminuria, macroalbuminuria, or who currently smoke, but who do not have established corornary heart disease or other macrovascular disease.</brief_summary>
	<brief_title>CARDS Is Designed To Show If Lowering Cholesterol With Atorvastatin In Type 2 Diabetics Without CV Disease Reduces The Risk Of CV Events</brief_title>
	<detailed_description />
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Angina, Unstable</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<criteria>Patients must have a documented history of at least one of the following: Hypertension (defined as systolic blood pressure 140 mmHg or a diastolic blood pressure 90 mmHg (defined as the disapperance of all sound [Korotkoff Phase V] or receiving antihypertensive treatment. Blood pressure should be measured after sitting the patient quietly for 3 minutes). Retinopathy (defined as any of the following; nonproliferative retinopathy, prepreproliferative retinopathy, proliferative retinopathy, maculopathy, advanced diabetic eye disease or history of photocoagulation). Microalbuminuria (defined as either, Albumin creatinine ratio &gt; than = to 2.5 mg/mmol, or Albumin excretion rate on a timed collection &gt; than = to 20 mcg/min (&gt; than = to 30 mg/24hrs) on two successive occasions, or a positive micral or other strip test). Macroalbuminuria (defined as either; Albustix or other dipstick evidence of gross proteinuria, Albumin creatinine ratio &gt; than = to 25 mg/mmol; or Albumin excretion rate on a timed collection &gt; than = 200 mcg/min (&gt; than = 300 mg/24hrs) on two sucessive occasions). Current smoker Type I Diabetes Mellitus Any major Coronary event prior to entry into the study</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>May 2007</verification_date>
</DOC>